MARKSANS PHARMA LTD.
Quaterly Results
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Audited / UnAudited | UnAudited | UnAudited | UnAudited | UnAudited |
Net Sales | 5861.27 | 5312.36 | 5000.33 | 4859.76 |
Total Expenditure | 4531.05 | 4172.87 | 3980.67 | 3764.27 |
PBIDT (Excl OI) | 1330.22 | 1139.49 | 1019.66 | 1095.49 |
Other Income | 48 | 189.96 | 100.96 | 110.09 |
Operating Profit | 1378.22 | 1329.45 | 1120.62 | 1205.58 |
Interest | 31.61 | 16.26 | 15.76 | 24.4 |
Exceptional Items | NA | NA | NA | NA |
PBDT | 1346.61 | 1313.19 | 1104.86 | 1181.18 |
Depreciation | 220.03 | 175.51 | 136.6 | 139.44 |
Profit Before Tax | 1126.58 | 1137.68 | 968.26 | 1041.74 |
Tax | 296.93 | 299.18 | 263.88 | 214.64 |
Provisions and contingencies | NA | NA | NA | NA |
Profit After Tax | 829.65 | 838.5 | 704.38 | 827.1 |
Extraordinary Items | NA | NA | NA | NA |
Prior Period Expenses | NA | NA | NA | NA |
Other Adjustments | NA | NA | NA | NA |
Net Profit | 829.65 | 838.5 | 704.38 | 827.1 |
Minority Interest | 2.7 | -3.32 | -17.8 | -7.78 |
Shares of Associates | ||||
Other related items | ||||
Misc. Expenses Written off | NA | NA | NA | NA |
Consolidated Net Profit | 832.35 | 835.18 | 686.58 | 819.32 |
Equity Capital | 453.16 | 453.16 | 453.16 | 453.16 |
Face Value (IN RS) | 1 | 1 | 1 | 1 |
Reserves | NA | NA | NA | NA |
Calculated EPS | 1.83 | 1.84 | 1.51 | 1.80 |
Calculated EPS (Annualised) | 7.34 | 7.37 | 6.06 | 7.23 |
No of Public Share Holdings | 254452013 | 254452013 | 254452013 | 254452013 |
% of Public Share Holdings | 56.15 | 56.15 | 56.15 | 56.15 |
| NA | NA | NA | NA |
PBIDTM% (Excl OI) | 22.69 | 21.44 | 20.39 | 22.54 |
PBIDTM% | 23.51 | 25.02 | 22.41 | 24.80 |
PBDTM% | 22.97 | 24.71 | 22.09 | 24.30 |
PBTM% | 19.22 | 21.41 | 19.36 | 21.43 |
PATM% | 14.15 | 15.78 | 14.08 | 17.01 |
"; | Notes | Notes | Notes | Notes |